XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 22,125 $ 12,693
General and administrative 8,085 4,995
Total operating expenses 30,210 17,688
Loss from operations (30,210) (17,688)
Other income (expense):    
Interest income and other income, net 5,018 139
Total other income, net 5,018 139
Net loss $ (25,192) $ (17,549)
Net loss per share attributable to common stockholders, basic $ (0.44) $ (0.36)
Net loss per share attributable to common stockholders, diluted $ (0.44) $ (0.36)
Weighted average shares of common stock outstanding, basic 56,703,873 48,284,778
Weighted average shares of common stock outstanding, diluted 56,703,873 48,284,778
Comprehensive loss:    
Net loss $ (25,192) $ (17,549)
Other comprehensive income (loss):    
Unrealized gains (losses) on marketable securities 192 (791)
Comprehensive loss $ (25,000) $ (18,340)